Skip to main content
Erschienen in: Cancer Causes & Control 7/2006

01.09.2006 | Original Paper

Risk patterns of multiple myeloma in Los Angeles County, 1972–1999 (United States)

verfasst von: Mulugeta Gebregziabher, Leslie Bernstein, Yaping Wang, Wendy Cozen

Erschienen in: Cancer Causes & Control | Ausgabe 7/2006

Einloggen, um Zugang zu erhalten

Abstract

Objective

To describe the risk patterns of multiple myeloma in Los Angeles County (LAC).

Methods

Incident multiple myeloma cases diagnosed from 1972 to 1999 were ascertained by the population-based cancer registry for LAC. Average annual age-specific and age-adjusted incidence rates (AAIR), standardized to the 2000 US census age distribution, were calculated using age-, race-, sex- and socioeconomic status (SES)-specific denominators estimated for all years from US census data for 1970, 1980 and 1990. Odds ratios (ORs) for risk by birthplace and religion were estimated using multivariate logistic regression, comparing multiple myeloma patients with other cancer patients.

Results

All groups experienced increasing incidence with age; African-Americans experienced the steepest increase which began a decade earlier compared to other groups. Overall incidence rates were 50% higher among males (n = 4,692) than females (n = 4,343) (< 0.05). AAIRs were highest for African-Americans, followed by Spanish-surnamed whites (SSW), non-Spanish-surnamed whites (NSSW), Filipinos and other Asian groups. Among African-Americans, incidence rates increased with increasing SES. US-born SSW had 14% lower risk compared to non-US born SSW (OR = 0.86, 95% confidence interval [CI] = 0.74–0.99]. Jews had an 11% higher risk compared to Protestants (OR = 1.11; 95% CI = 0.99–1.24).

Conclusion

Risk patterns suggest a role for both environmental and genetic factors.
Literatur
1.
Zurück zum Zitat Morgan G, Davies F, Linet M (2002) Myeloma aetiology and epidemiology. Biomed Pharmacother 56:223–234PubMedCrossRef Morgan G, Davies F, Linet M (2002) Myeloma aetiology and epidemiology. Biomed Pharmacother 56:223–234PubMedCrossRef
2.
Zurück zum Zitat Kosmas C, Stamatopoulos K, Stavroyianni N, et al (2000) Origin and diversification of the clonogenic cell in multiple myeloma: lessons from the immunoglobulin repertoire. Leukemia 14:1718–1726PubMedCrossRef Kosmas C, Stamatopoulos K, Stavroyianni N, et al (2000) Origin and diversification of the clonogenic cell in multiple myeloma: lessons from the immunoglobulin repertoire. Leukemia 14:1718–1726PubMedCrossRef
4.
Zurück zum Zitat Herrinton L, Weiss N, Olshan A (1996) Multiple myeloma. In: Schottenfeld D, Fraumeni JJ (eds) Cancer epidemiology and prevention. Oxford University Press, New York, pp 946–970 Herrinton L, Weiss N, Olshan A (1996) Multiple myeloma. In: Schottenfeld D, Fraumeni JJ (eds) Cancer epidemiology and prevention. Oxford University Press, New York, pp 946–970
5.
Zurück zum Zitat Bergasel D (1995) The incidence and epidemiology of plasma cell neoplasms. Stem Cells 13(supplement 2):1–9 Bergasel D (1995) The incidence and epidemiology of plasma cell neoplasms. Stem Cells 13(supplement 2):1–9
6.
Zurück zum Zitat Miller B, Kolonel L, Bernstein L, et al (1996) Racial/ethnic patterns of cancer in the United States 1988–1992. National Cancer Institute, Bethesda, MD. NIH Pub. No. 96-4104 Miller B, Kolonel L, Bernstein L, et al (1996) Racial/ethnic patterns of cancer in the United States 1988–1992. National Cancer Institute, Bethesda, MD. NIH Pub. No. 96-4104
7.
Zurück zum Zitat Koessel S, Theis M, Vaughan T, et al (1996) Socioeconomic status and the incidence of multiple myeloma. Epidemiology 7:1–3 Koessel S, Theis M, Vaughan T, et al (1996) Socioeconomic status and the incidence of multiple myeloma. Epidemiology 7:1–3
8.
Zurück zum Zitat Pasqualetti P, Casale R, Collacciani A, Colantonio D (1990) Work activities and the risk of multiple myeloma: a case–control study. Med Lav 81:308–319PubMed Pasqualetti P, Casale R, Collacciani A, Colantonio D (1990) Work activities and the risk of multiple myeloma: a case–control study. Med Lav 81:308–319PubMed
9.
Zurück zum Zitat Baris D, Brown L, Silverman D, et al (2000) Socioeconomic status and multiple myeloma among US blacks and whites. Am J Public Health 90(8):1277–1281PubMed Baris D, Brown L, Silverman D, et al (2000) Socioeconomic status and multiple myeloma among US blacks and whites. Am J Public Health 90(8):1277–1281PubMed
10.
Zurück zum Zitat Johnston J, Grufferman S, Bourguet C, Delzell E, Delong E, Cohen H (1985) Socioeconomic status and risk of multiple myeloma. Epidemiol Commun Health J 39:175–178CrossRef Johnston J, Grufferman S, Bourguet C, Delzell E, Delong E, Cohen H (1985) Socioeconomic status and risk of multiple myeloma. Epidemiol Commun Health J 39:175–178CrossRef
11.
Zurück zum Zitat Figgs L, Dosemeci M, Blair A (1994) Risk of multiple myeloma by occupation and industry among men and women: a 24-state death certificate study. J Occup Med 36:1210–1221PubMed Figgs L, Dosemeci M, Blair A (1994) Risk of multiple myeloma by occupation and industry among men and women: a 24-state death certificate study. J Occup Med 36:1210–1221PubMed
12.
Zurück zum Zitat Mack T (1977) Cancer surveillance program in Los Angeles County. Nat Cancer Inst Monogr 47:99–101PubMed Mack T (1977) Cancer surveillance program in Los Angeles County. Nat Cancer Inst Monogr 47:99–101PubMed
13.
Zurück zum Zitat Fritz A, Percy C, Jack A, et al (eds) (2000) International classification of diseases for oncology. 3rd edn. World Health Association, Geneva Fritz A, Percy C, Jack A, et al (eds) (2000) International classification of diseases for oncology. 3rd edn. World Health Association, Geneva
14.
Zurück zum Zitat Boyle P, Parkin D (1991) Statistical methods for registries. International Agency for Research on Cancer, Lyon, France Boyle P, Parkin D (1991) Statistical methods for registries. International Agency for Research on Cancer, Lyon, France
15.
Zurück zum Zitat Liu L, Deapen D, Bernstein L (1998) Socioeconomic status and cancer of the female breast and reproductive organs: a comparison across racial/ethnic population in Los Angeles County, California (United states). Cancer Causes Controls 9:369–380CrossRef Liu L, Deapen D, Bernstein L (1998) Socioeconomic status and cancer of the female breast and reproductive organs: a comparison across racial/ethnic population in Los Angeles County, California (United states). Cancer Causes Controls 9:369–380CrossRef
16.
Zurück zum Zitat Riedel D, Pottern L (1992) The epidemiology of multiple myeloma. Hematol Oncol Clin N Am 6(2):225–247 Riedel D, Pottern L (1992) The epidemiology of multiple myeloma. Hematol Oncol Clin N Am 6(2):225–247
17.
Zurück zum Zitat Hernandez J, Land K, McKenna R (1995) Leukemias, myeloma and other lymphoreticular neoplasms. Cancer 75(1 Suppl):381–394PubMedCrossRef Hernandez J, Land K, McKenna R (1995) Leukemias, myeloma and other lymphoreticular neoplasms. Cancer 75(1 Suppl):381–394PubMedCrossRef
18.
Zurück zum Zitat Walker B, Figgs L, Zahm S (1995) Differences in cancer incidence, mortality, and survival between African Americans and whites. Environ Health Perspect 103(supplement 8):275–281PubMed Walker B, Figgs L, Zahm S (1995) Differences in cancer incidence, mortality, and survival between African Americans and whites. Environ Health Perspect 103(supplement 8):275–281PubMed
19.
Zurück zum Zitat Benjamin M, Reddy S, Brawley O (2003) Myeloma and race: a review of the literature. Cancer Metastatsis Rev 22:87–93CrossRef Benjamin M, Reddy S, Brawley O (2003) Myeloma and race: a review of the literature. Cancer Metastatsis Rev 22:87–93CrossRef
20.
Zurück zum Zitat Grulich A, Swerdlow A, Head J, Marmot M (1992) Cancer mortality in African and Caribbean migrants to England and Wales. Br J Cancer 66(5):905–911PubMed Grulich A, Swerdlow A, Head J, Marmot M (1992) Cancer mortality in African and Caribbean migrants to England and Wales. Br J Cancer 66(5):905–911PubMed
21.
Zurück zum Zitat Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB (eds) (2002) Cancer in five continents; IARC Scientific Publications No. 155. International Agency for Research on Cancer, Lyon, France Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB (eds) (2002) Cancer in five continents; IARC Scientific Publications No. 155. International Agency for Research on Cancer, Lyon, France
22.
Zurück zum Zitat Nossent J, Winkel C, van Leeuwen J (1993) Multiple myeloma in the Afro-Caribbean population of Curacao. Neth J Med 43(5–6):210–214PubMed Nossent J, Winkel C, van Leeuwen J (1993) Multiple myeloma in the Afro-Caribbean population of Curacao. Neth J Med 43(5–6):210–214PubMed
23.
Zurück zum Zitat Besson C, Gonin C, Brebion A, Delaunay C, Panelatti G, Plumelle Y (2001) Incidence of hematological malignancies in Martinique, French West Indies, overrepresentation of multiple myeloma and adult T cell leukemia/lymphoma. Leukemia 15:828–831PubMedCrossRef Besson C, Gonin C, Brebion A, Delaunay C, Panelatti G, Plumelle Y (2001) Incidence of hematological malignancies in Martinique, French West Indies, overrepresentation of multiple myeloma and adult T cell leukemia/lymphoma. Leukemia 15:828–831PubMedCrossRef
24.
Zurück zum Zitat Cozen W, Katz J, Mack T (1992) Risk patterns of Hodgkin’s disease in Los Angeles vary by cell type. Cancer Epidemiol Biomarkers Preven 1:261–268 Cozen W, Katz J, Mack T (1992) Risk patterns of Hodgkin’s disease in Los Angeles vary by cell type. Cancer Epidemiol Biomarkers Preven 1:261–268
25.
Zurück zum Zitat Gale R, Cozen W, Goodman M, Wang F, Bernstein L (2000) Decreased chronic lymphocytic leukemia incidence in Asians in Los Angeles County. Leuk Res 24:665–669PubMedCrossRef Gale R, Cozen W, Goodman M, Wang F, Bernstein L (2000) Decreased chronic lymphocytic leukemia incidence in Asians in Los Angeles County. Leuk Res 24:665–669PubMedCrossRef
26.
Zurück zum Zitat Mack T, Walker A, Mack W, Bernstein L (1985) Cancer in hispanics in Los Angeles County. Nat Cancer Inst Monogr 69:99–104PubMed Mack T, Walker A, Mack W, Bernstein L (1985) Cancer in hispanics in Los Angeles County. Nat Cancer Inst Monogr 69:99–104PubMed
27.
Zurück zum Zitat Shulman G, Jacobson R (1980) Immunocytoma in black and white South Africans. Trop Geogr Med 32(2):112–117PubMed Shulman G, Jacobson R (1980) Immunocytoma in black and white South Africans. Trop Geogr Med 32(2):112–117PubMed
28.
Zurück zum Zitat Devesa S, Silverman D, Young JJ, et al (1987) Cancer incidence and mortality trends among whites in the United States, 1947–84. JNCI 79(4):701–710PubMed Devesa S, Silverman D, Young JJ, et al (1987) Cancer incidence and mortality trends among whites in the United States, 1947–84. JNCI 79(4):701–710PubMed
29.
Zurück zum Zitat Boffetta P, Stellman S, Garfinkel L (1989) A case-control study of multiple myeloma nested in the American Cancer Society prospective study. Int J Cancer 43:554–559PubMed Boffetta P, Stellman S, Garfinkel L (1989) A case-control study of multiple myeloma nested in the American Cancer Society prospective study. Int J Cancer 43:554–559PubMed
30.
Zurück zum Zitat Bernstein L, Newton P, Ross R (1889) Epidemiology of hairy cell leukemia in Los Angeles County. Cancer Res 50(12):3605–3609 Bernstein L, Newton P, Ross R (1889) Epidemiology of hairy cell leukemia in Los Angeles County. Cancer Res 50(12):3605–3609
31.
Zurück zum Zitat Mack T, Berkel J, Bernstein L, Mack W (1985) Religion and cancer in Los Angeles County. Nat Cancer Inst Monogr 69:235–245PubMed Mack T, Berkel J, Bernstein L, Mack W (1985) Religion and cancer in Los Angeles County. Nat Cancer Inst Monogr 69:235–245PubMed
32.
Zurück zum Zitat Kishimoto T (2003) Interleukin-6 (IL-6). In: Thomson A, Lotze M (eds) The cytokine handbook. Academic Press, London pp 281–304 Kishimoto T (2003) Interleukin-6 (IL-6). In: Thomson A, Lotze M (eds) The cytokine handbook. Academic Press, London pp 281–304
33.
Zurück zum Zitat Lauta V (2003) A review of the cytokine network in multiple myeloma: diagnostic, prognostic, and therapeutic implications. Cancer 97(10):2440–2552PubMedCrossRef Lauta V (2003) A review of the cytokine network in multiple myeloma: diagnostic, prognostic, and therapeutic implications. Cancer 97(10):2440–2552PubMedCrossRef
34.
Zurück zum Zitat Michalaki V, Syrigos K, Charles P, Waxman J (2004) Serum levels of IL-6 and TNF-alpha correlate with clinicopathological features and patient survival in patients with prostate cancer. BrJ Cancer 90(12):2312–2316 Michalaki V, Syrigos K, Charles P, Waxman J (2004) Serum levels of IL-6 and TNF-alpha correlate with clinicopathological features and patient survival in patients with prostate cancer. BrJ Cancer 90(12):2312–2316
35.
Zurück zum Zitat Martin A, Athanasiadis G, Greshock J, et al (2003) Population frequencies of single nucleotide polymorphisms (SNPs) in immuno-modulatory genes. Human Hered 55:171–176CrossRef Martin A, Athanasiadis G, Greshock J, et al (2003) Population frequencies of single nucleotide polymorphisms (SNPs) in immuno-modulatory genes. Human Hered 55:171–176CrossRef
36.
Zurück zum Zitat Delaney N, Esquenazi V, Lucas D, Zachary A, Leffell M (2004) TNF-alpha, TFG-beta, IL-10, IL-6, and INF-gamma alleles among African Americans and Cuban Americans. Report of the ASHI minority workshops: Part IV. Human Immunol 65:1413–1419 Delaney N, Esquenazi V, Lucas D, Zachary A, Leffell M (2004) TNF-alpha, TFG-beta, IL-10, IL-6, and INF-gamma alleles among African Americans and Cuban Americans. Report of the ASHI minority workshops: Part IV. Human Immunol 65:1413–1419
37.
Zurück zum Zitat Hoffmann S, Stanley E, Cox E, et al (2002) Ethnicity greatly influences cytokine gene polymorphism distribution. Am J Transplant 2:560–567PubMedCrossRef Hoffmann S, Stanley E, Cox E, et al (2002) Ethnicity greatly influences cytokine gene polymorphism distribution. Am J Transplant 2:560–567PubMedCrossRef
38.
Zurück zum Zitat Lim C, Zheng S, Kim Y, et al (2002) The –174 G to C polymorphism of interleukin-6 gene is very rare in koreans. Cytokine 19:52–54PubMedCrossRef Lim C, Zheng S, Kim Y, et al (2002) The –174 G to C polymorphism of interleukin-6 gene is very rare in koreans. Cytokine 19:52–54PubMedCrossRef
39.
Zurück zum Zitat Zheng C, Huang D, Bergenbrant S, et al (2000) Interleukin 6, tumour necrosis factor [alpha], interleukin 1 [beta] and interleukin 1 receptor antagonist promoter or coding gene polymorphisms in multiple myeloma. Br J Haematol 109(1):39–45PubMedCrossRef Zheng C, Huang D, Bergenbrant S, et al (2000) Interleukin 6, tumour necrosis factor [alpha], interleukin 1 [beta] and interleukin 1 receptor antagonist promoter or coding gene polymorphisms in multiple myeloma. Br J Haematol 109(1):39–45PubMedCrossRef
40.
Zurück zum Zitat Dring A, FE Davis, Rollinson S, et al (2001) Interleukin 6, tumour necrosis factor [alpha] and lymphotoxin [alpha] polymorphisms in monoclonal gammopathy of uncertain significance and multiple myeloma. Br J Haematol 112(1):249–250PubMedCrossRef Dring A, FE Davis, Rollinson S, et al (2001) Interleukin 6, tumour necrosis factor [alpha] and lymphotoxin [alpha] polymorphisms in monoclonal gammopathy of uncertain significance and multiple myeloma. Br J Haematol 112(1):249–250PubMedCrossRef
41.
Zurück zum Zitat Iakupova E, Grinchuk O, Kalimullina D, et al (2003) Molecular genetic analysis of the interleukin 6 and tumor necrosis factor alpha gene polymorphisms in multiple myeloma. Mol Biol 37(3):420–424 Iakupova E, Grinchuk O, Kalimullina D, et al (2003) Molecular genetic analysis of the interleukin 6 and tumor necrosis factor alpha gene polymorphisms in multiple myeloma. Mol Biol 37(3):420–424
42.
Zurück zum Zitat Mazur G, Bogunia-Kubik K, Wrobel T, et al (2005) IL-6 and IL-10 promoter gene polymorphisms do not associate with the susceptibility for multiple myeloma. Immunol Lett 96:241–246PubMedCrossRef Mazur G, Bogunia-Kubik K, Wrobel T, et al (2005) IL-6 and IL-10 promoter gene polymorphisms do not associate with the susceptibility for multiple myeloma. Immunol Lett 96:241–246PubMedCrossRef
43.
Zurück zum Zitat Peng B, Hodge D, Thomas S, et al (2005) Epigenetic silencing of the human nucleotide excision repair gene, hHR23B, in interleukin-6-responsive multiple myeloma KAS-6/1 cells. J Biol Chem 280(6):4182–4187PubMedCrossRef Peng B, Hodge D, Thomas S, et al (2005) Epigenetic silencing of the human nucleotide excision repair gene, hHR23B, in interleukin-6-responsive multiple myeloma KAS-6/1 cells. J Biol Chem 280(6):4182–4187PubMedCrossRef
44.
Zurück zum Zitat Velangi M, Matheson E, Morgan G, et al (2004) DNA mismatch repair pathway defects in the pathogenesis and evolution of myeloma. Carcinogenesis 25(10):1795–1803PubMedCrossRef Velangi M, Matheson E, Morgan G, et al (2004) DNA mismatch repair pathway defects in the pathogenesis and evolution of myeloma. Carcinogenesis 25(10):1795–1803PubMedCrossRef
Metadaten
Titel
Risk patterns of multiple myeloma in Los Angeles County, 1972–1999 (United States)
verfasst von
Mulugeta Gebregziabher
Leslie Bernstein
Yaping Wang
Wendy Cozen
Publikationsdatum
01.09.2006
Verlag
Kluwer Academic Publishers
Erschienen in
Cancer Causes & Control / Ausgabe 7/2006
Print ISSN: 0957-5243
Elektronische ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-006-0030-x

Weitere Artikel der Ausgabe 7/2006

Cancer Causes & Control 7/2006 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.